Health and Education Notices




APRIL

NEW ZEALAND GAZETTE

907

Acting through the Senior Manager, National Operations,
Ministry of Education, pursuant to delegated authority, and
the proprietor of the following school:

St John’s Girls’ School, Invercargill.

The said supplementary agreement was executed on the
20th day of March 1995. A copy of the supplementary
agreement is available for inspection without charge by any
member of the public at the district office of the Ministry of
Education, 123 Victoria Street, Christchurch.

Dated at Wellington this 30th day of March 1995.

KATHY PHILLIPS, Senior Manager, National Operations.

no2202


Dated this 30th day of March 1995.

DAVID SMYTH, Acting Director-General of Health,
pursuant to the delegation given by the Minister of Health
on the 25th day of June 1993.

go2260

Health

Medicines Act 1981

Corrigendum

Consent to the Distribution of New Medicines

In the notice published in the New Zealand Gazette,
9 March 1995, No. 22, page 695, notice No. 1678, (i) for
the first reference to the word “Fongitar”, in the
twenty-eighth line, replace with the word “poltar”. The
active ingredients for the product Fongitar then read
“Poltar 1 % w/w, pyrithione zinc 1 % w/w”.

Dated this 30th day of March 1995.

DAVID SMYTH, Acting Director-General of Health,
pursuant to the delegation given by the Minister of Health
on the 25th day of June 1993.

go2259

Corrigendum

Consent to the Distribution of Changed Medicines

In the notice published in the New Zealand Gazette, 9
March 1995, No. 22, page 695, notice No. 1650, (i) for the
word “interferon” in the thirty-ninth line, replace with the
word “Hoffmann” and (ii) for the word “Hoffman” in the
thirty-ninth line, replace with the word “Hoffmann”. This
in respect of the product Roferon-A.

Dated this 30th day of March 1995.

DAVID SMYTH, Acting Director-General of Health,
pursuant to the delegation given by the Minister of Health
on the 25th day of June 1993.

go2259

Classification of Medicines

Pursuant to section 106 (1) of the Medicines Act 1981, the
Minister of Health hereby declares the medicines listed in
Schedules one and two to this notice to have the
classifications prescription medicine and restricted
medicine respectively.

First Schedule

Prescription Medicines

Adenosine
Dorzolamide
Dalteparin sodium
Cladribine
Nadroparin calcium
Pantoprazole
Quinagolide
Recombinant mecasermin
Tinzaparin sodium

Second Schedule

Restricted Medicines

Ibuprofen; in liquid form for oral use in medicines which
have received the Minister’s consent to their distribution as
restricted medicines and which are sold in the
manufacturer’s original pack containing 200 millilitres or
less in volume and in strengths of 100 milligrams or less
per 5 millilitres.

Dated this 21st day of March 1995.

MAURICE WILLIAMSON, Associate Minister of Health.

go2215

Renewal of Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in
New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Hepatitis B Immunoglobulin (Human) 16% w/v in 100IU and 400IU solution for IM injection (ampoule) CSL Limited, Parkville, Victoria, Australia Hepatitis B Immunoglobulin (Human)
Note: This consent is effective from 25 February 1995
Dried Factor VIII Fraction 250IU in 10 mL powder for reconstitution for IV injection (vial) CSL Limited, Broadmeadows, Victoria, Australia AHF (High Purity) Dried Factor VIII Fraction
Note: This consent is effective from 25 February 1995
Tetanus Immunoglobulin (Human) 16% w/v in 250IU solution for IM injection (ampoule) CSL Limited, Parkville, Victoria, Australia Tetanus Immunoglobulin (Human)
Note: This consent is effective from 25 February 1995


Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1995, No 31


NZLII PDF NZ Gazette 1995, No 31





✨ LLM interpretation of page content

🎓 Supplementary Agreement for St John’s Girls’ School

🎓 Education, Culture & Science
30 March 1995
Education, Supplementary Agreement, St John’s Girls’ School, Invercargill
  • KATHY PHILLIPS, Senior Manager, National Operations

🏥 Corrigendum to Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
30 March 1995
Medicines, Corrigendum, Fongitar, Poltar, Pyrithione Zinc
  • DAVID SMYTH, Acting Director-General of Health

🏥 Corrigendum to Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
30 March 1995
Medicines, Corrigendum, Roferon-A, Interferon, Hoffmann
  • DAVID SMYTH, Acting Director-General of Health

🏥 Classification of Medicines

🏥 Health & Social Welfare
21 March 1995
Medicines, Classification, Prescription Medicines, Restricted Medicines, Adenosine, Dorzolamide, Dalteparin Sodium, Cladribine, Nadroparin Calcium, Pantoprazole, Quinagolide, Recombinant Mecasermin, Tinzaparin Sodium, Ibuprofen
  • MAURICE WILLIAMSON, Associate Minister of Health

🏥 Renewal of Provisional Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
Medicines, Provisional Consent, Hepatitis B Immunoglobulin, Factor VIII Fraction, Tetanus Immunoglobulin